Literature DB >> 28874233

Predominance of clarithromycin-susceptible Mycobacterium massiliense subspecies: Characterization of the Mycobacterium abscessus complex at a tertiary acute care hospital.

Ka Lip Chew1, Janet W S Cheng1, Nurul Hudaa Osman1, Raymond T P Lin1,2, Jeanette W P Teo1.   

Abstract

To characterize members of the Mycobacterium abscessus complex, with an emphasis on the correlation between species identification and clarithromycin associated genetic polymorphisms that contribute to inducible and constitutive macrolide resistance. PCR and sequencing analysis was used to elucidate the subspecies, erm(41) genotypes and the presence of rrl mutations. M. abscessus subsp. massiliense was the dominant subspecies (70.2 %), followed by M. abscessus subsp. abscessus (23.8 %) and M. abscessus subsp. bolletii (5.9 %). The majority of M. abscessus and M. bolletii isolates possessed T28 erm(41) sequevar and were inducibly resistant to clarithromycin. All M. massiliense carried the truncated erm(41) and were largely clarithromycin-susceptible (98.3 %). Constitutive resistance involving rrl mutations was rare and seen in only 2 isolates (2.2 %). Subspecies identification was insufficient to predict clarithromycin susceptibility and required the genetic resistance to be determined via sequencing. In our context, rrl mutations were uncommon and may not be an essential test.

Entities:  

Keywords:  PCR; inducible drug resistance; macrolides; nontuberculous mycobacteria (NTM); sequencing

Mesh:

Substances:

Year:  2017        PMID: 28874233     DOI: 10.1099/jmm.0.000576

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

1.  Whole-Genome Sequencing for Predicting Clarithromycin Resistance in Mycobacterium abscessus.

Authors:  Samuel Lipworth; Natasha Hough; Laura Leach; Marcus Morgan; Katie Jeffery; Monique Andersson; Esther Robinson; E Grace Smith; Derrick Crook; Tim Peto; Timothy Walker
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

2.  Optimized analysis parameters of variant calling for whole genome-based phylogeny of Mycobacteroides abscessus.

Authors:  Orawee Kaewprasert; Sissades Tongsima; Rick Twee-Hee Ong; Kiatichai Faksri
Journal:  Arch Microbiol       Date:  2022-02-22       Impact factor: 2.552

3.  Molecular epidemiology and phylogenomic analysis of Mycobacterium abscessus clinical isolates in an Asian population.

Authors:  Ka Lip Chew; Sophie Octavia; Roland Jureen; Oon Tek Ng; Kalisvar Marimuthu; Raymond Tzer Pin Lin; Jeanette W P Teo
Journal:  Microb Genom       Date:  2021-11

4.  Tedizolid Activity Against Clinical Mycobacterium abscessus Complex Isolates-An in vitro Characterization Study.

Authors:  Ying Wei Tang; Bernadette Cheng; Siang Fei Yeoh; Raymond T P Lin; Jeanette W P Teo
Journal:  Front Microbiol       Date:  2018-09-07       Impact factor: 5.640

5.  In Vitro Synergy Testing of Eravacycline in Combination with Clarithromycin and Rifabutin against Mycobacterium abscessus Complex.

Authors:  Ka Lip Chew; Sophie Octavia; Siang Fei Yeoh; Jeanette W P Teo
Journal:  Microbiol Spectr       Date:  2021-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.